论文部分内容阅读
近10年来,肺动脉高压(PAH)的病因学研究所取得的重大进展,不仅有利于更加深入地认识该疾病的发病机制,也为临床治疗提供了新的治疗靶点。11PAH发病的分子机制1.1骨形成蛋白Ⅱ型受体(BMPR2)基因突变骨形成蛋白(Bone Morphonenetic Protein,BMP)是转移生长因子β(TGF-β)家族中最
In the recent 10 years, the great progress made in the etiological study of pulmonary hypertension (PAH) not only helps to better understand the pathogenesis of this disease, but also provides a new therapeutic target for clinical treatment. 11 The pathogenesis of PAH 1.1 Bone morphogenetic type Ⅱ receptor (BMPR2) gene mutation Bone morphogenetic protein (BMP) is a member of the metastatic growth factor β (TGF-β) family